SYNTEX CORP
SC 14D1/A, 1994-08-03
PHARMACEUTICAL PREPARATIONS
Previous: SUNDSTRAND CORP /DE/, 10-Q, 1994-08-03
Next: PHOENIX RESOURCE COMPANIES INC, 10-Q, 1994-08-03



==============================================================================

                      SECURITIES AND EXCHANGE COMMISSION
                            Washington, D. C. 20549

                                ---------------

                                AMENDMENT NO. 7
                                      TO
                                SCHEDULE 14D-1

                  Tender Offer Statement Pursuant to Section
                14(d)(1) of the Securities Exchange Act of 1934

                              Syntex Corporation
                           (Name of Subject Company)

                           Roche Capital Corporation
                                   (Bidder)

                    Common Stock, Par Value $1.00 Per Share
                        (Title of Class of Securities)

                                   87161610
                     (CUSIP Number of Class of Securities)

                               Dr. Felix Amrein
                             c/o Roche Holding Ltd
                             Grenzacherstrasse 124
                                 CH-4002 Basel
                                  Switzerland
                         Telephone: (41) (61) 688-1111
  (Name, Address and Telephone Number of Person Authorized to Receive Notices
                    and Communications on Behalf of Bidder)

                                ---------------

                                  Copies to:
                               Peter R. Douglas
                             Davis Polk & Wardwell
                             450 Lexington Avenue
                           New York, New York  10017
                          Telephone:  (212) 450-4000


                                  May 6, 1994

                                ---------------

     Date Tender Offer First Published, Sent or Given to Security Holders

==============================================================================



CUSIP No.  871 616 10


1   NAME OF REPORTING PERSON
    S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
        Roche Capital Corporation


2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
                                                          (a)  [ ]
                                                          (b)  [ ]
3   SEC USE ONLY

4   SOURCE OF FUNDS*
        AF

5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
    TO ITEMS 2 (e) OR 2 (f) [ ]

6   CITIZENSHIP OR PLACE OF ORGANIZATION
        Panama

7   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
        0

8   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (7) EXCLUDES CERTAIN SHARES*  [ ]

9   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (7)
        N/A

10  TYPE OF REPORTING PERSON*
        CO



     This Amendment No. 7 amends and supplements the Tender Offer Statement
on Schedule 14D-1 (the "Statement") dated May 6, 1994 filed by Roche
Capital Corporation, a Panama corporation (the "Bidder") and a wholly owned
subsidiary of Sapac Corporation Limited, a non-resident Canadian
corporation ("Holding"), which, in turn, is a wholly owned subsidiary of
Roche Holding Ltd, a Switzerland corporation ("Parent"), as amended by
Amendments Nos. 1, 2, 3, 4, 5 and 6 relating to the Bidder's offer to
purchase all outstanding shares of Common Stock, $1.00 par value (the
"Shares") of Syntex Corporation (the "Company"), at $24.00 per Share, net
to the seller in cash, upon the terms and subject to the conditions set
forth in the Offer to Purchase and the related Letter of Transmittal,
copies of which are attached as Exhibits (a)(1) and (a)(2) to the Statement
(which are herein referred to as the "Offer").  Capitalized terms not
separately defined herein shall have the meanings specified in the
Statement.

Item 10.  Additional Information.

     (c)  On August 3, 1994, the Bidder and the Company issued the joint press
release attached hereto as Exhibit (a)(10).  The information set forth in the
press release is incorporated herein by reference.

Item 11.  Material to be Filed as Exhibits.

     (a)(10)  Joint Press Release, dated August 3, 1994.

                                 SIGNATURE

     After due inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and
correct.

                                        ROCHE CAPITAL CORPORATION


                                        By: /s/ DR. HENRI B. MEIER
                                           _______________________
                                                Dr. Henri B. Meier
                                                Vice-President



Dated: August 3, 1994

                                                            EXHIBIT (a)(10)
FOR IMMEDIATE RELEASE


         ROCHE HOLDING LTD EXTENDS TENDER OFFER FOR SYNTEX CORPORATION


BASEL, SWITZERLAND AND PALO ALTO, CALIFORNIA -- August 3, 1994 -- Roche
Holding Ltd and Syntex Corporation (NYSE:  SYN) announced today that Roche
Capital Corporation is extending its offer to purchase all outstanding
shares of common stock of Syntex for $24.00 in cash until Wednesday, August
24, 1994.  The offer is being extended to provide time to comply with the
request for additional information made by the U.S. Federal Trade
Commission pursuant to the Hart-Scott-Rodino Antitrust Improvements Act in
connection with Roche's ongoing tender offer.

     Roche Capital has extended the expiration date for the tender offer until
12:00 Midnight, New York City time, on Wednesday, August 24, 1994.  As a
consequence of the extension of the expiration date, holders of Syntex common
stock may tender or withdraw shares until 12:00 Midnight, New York City time,
on Wednesday, August 24, 1994, unless the offer is further extended.  The
tender offer was previously scheduled to expire on August 3, 1994.  It may be
necessary to extend the offer further to allow sufficient time for compliance
with the FTC's request.

     Based on the latest count of tendered shares, including shares
tendered pursuant to guarantees of delivery, approximately 132,000,000
shares of Syntex common stock have been validly tendered and not withdrawn
pursuant to the tender offer.

                                     # # #


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission